UROLOGICAL CANCER: GUIDANCE

Improving outcomes in urological cancers: cancer guidance

Background

To assist purchasers of healthcare to commission, plan and develop urological cancer services NICE issued guidance on the organisation of healthcare for people with a urological cancer. The guidance recommends which healthcare professionals should be involved in treatment and care, and the types of hospital or cancer centre that are best suited to provide that healthcare.

Although the guidance does sometimes refer to appropriate forms of investigation and treatment, it doesn't provide detailed information on these areas. CRD was commissioned to undertake the systematic review work that provided the evidence to support the recommendations in the guidance.

Findings

The key recommendations from the guidance were that people should be treated by a multidisciplinary team with the appropriate clinical skills; and that radical surgery for prostate and bladder cancer should be carried out by specialist teams. Information and support should be improved; and more research is needed on treatment.

Conducted by: CRD, the Velindre NHS Trust and the Department of Palliative Care and Policy, King's College School of Medicine and Dentistry

Related guidance

Commissioned to inform NICE cancer service guidance: National Cancer Guidance Steering Group. Improving outcomes in urological cancers: the manual. London: National Institute for Clinical Excellence; 2002

Centre for Reviews and Dissemination. Improving outcomes in urological cancers: the research evidence. York: University of York; 2002

Presentations

Flynn A, Burgon K, Coles B, Court J, Kleijnen J, Lewis R. Improving outcomes in urological cancers: evidence-based service guidance for the National Health Service in England and Wales. 5th International Conference on the Scientific Basis of Health Services; 2003 September; Washington DC, USA

Funding

Commissioned by NICE